Related Experiment Video
Updated: May 25, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
ERK2 drives tumour cell migration in three-dimensional microenvironments by suppressing expression of Rab17 and
Anne von Thun1, Marc Birtwistle, Gabriela Kalna
1Beatson Institute for Cancer Research, Glasgow, G61 1BD, UK.
Abstract:
Upregulation of the extracellular signal-regulated kinase (ERK) pathway has been shown to contribute to tumour invasion and progression. Because the two predominant ERK isoforms (ERK1 and ERK2, also known as MAPK3 and MAPK1, respectively) are highly homologous and have indistinguishable kinase activities in vitro, both enzymes were believed to be redundant and interchangeable. To challenge this view, we show that ERK2 silencing inhibits invasive migration of MDA-MB-231 cells, and re-expression of ERK2 but not ERK1 restores the normal invasive phenotype. A detailed quantitative analysis of cell movement on 3D matrices indicates that ERK2 knockdown impairs cellular motility by decreasing the migration velocity as well as increasing the time that cells spend not moving. Using gene expression arrays we found that the expression of the genes for Rab17 and liprin-β2 was increased by knockdown of ERK2 and restored to normal levels following re-expression of ERK2, but not ERK1. Both play inhibitory roles in the invasive behaviour of three independent cancer cell lines. Importantly, knockdown of either Rab17 or liprin-β2 restores invasiveness of ERK2-depleted cells, indicating that ERK2 drives invasion of MDA-MB-231 cells by suppressing expression of these genes.
Insights
Extracellular signal-regulated kinase 2 (ERK2) is crucial for cancer cell invasion, not redundant with ERK1. Suppressing ERK2 impairs cell motility by regulating Rab17 and liprin-β2 gene expression.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The extracellular signal-regulated kinase (ERK) pathway is implicated in tumor invasion and progression.
- ERK1 and ERK2 isoforms were considered redundant due to high homology and similar in vitro kinase activity.
Purpose of the Study:
- To investigate the specific roles of ERK1 and ERK2 in cancer cell invasion.
- To challenge the notion of functional redundancy between ERK1 and ERK2.
Main Methods:
- Silencing of ERK2 in MDA-MB-231 cells.
- Re-expression of ERK1 or ERK2 following knockdown.
- Quantitative analysis of cell migration on 3D matrices.
- Gene expression profiling using arrays.
Main Results:
- ERK2 silencing inhibited invasive migration of MDA-MB-231 cells, while ERK1 did not.
- ERK2 knockdown decreased cell migration velocity and increased non-motile time.
- Expression of Rab17 and liprin-β2 genes, which inhibit invasion, was upregulated by ERK2 knockdown.
- Re-expression of ERK2, but not ERK1, restored normal invasiveness and gene expression levels.
- Knockdown of Rab17 or liprin-β2 rescued invasiveness in ERK2-depleted cells.
Conclusions:
- ERK2 plays a non-redundant, critical role in driving cancer cell invasion.
- ERK2 promotes invasion by suppressing the expression of inhibitory genes Rab17 and liprin-β2.
- These findings highlight ERK2 as a potential therapeutic target for inhibiting cancer metastasis.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cancer Cell Migration through Invadopodia
Cell Polarization by Rho Proteins
PI3K/mTOR/AKT Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

